Osteoporosis Research Today is a free monthly online journal that collates and summarizes the latest research about Osteoporosis, including details on symptoms, treatment, prevention, causes.

Volume 4 (2007), Issue 6 (June)

1. Biomechanical in vitro testing of human osteoporotic lumbar vertebrae following prophylactic kyphoplasty with different candidate materials.
   Spine, 32(13): 1400-5. [Abstract] [Full-text]
2. Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic.
   Pharmacotherapy, 27(6): 779-88. [Abstract] [Full-text]
3. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease.
   Am J Respir Crit Care Med, 175(12): 1259-65. [Abstract] [Full-text]
4. Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.
   Nat Clin Pract Urol, 4(6): 310-20. [Abstract] [Full-text]
5. Is there a role for bisphosphonates in chronic kidney disease?
   Semin Dial, 20(3): 186-90. [Abstract] [Full-text]
6. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
   Arthritis Rheum, 56(6): 1966-73. [Abstract] [Full-text]
7. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
   Clin J Pain, 23(6): 511-7. [Abstract] [Full-text]
8. Farnesyl diphosphate synthase: a novel genotype association with bone mineral density in elderly women.
   Maturitas, 57(3): 247-52. [Abstract] [Full-text]
9. Isoflavone-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats.
   Maturitas, 57(3): 261-70. [Abstract] [Full-text]
10. Linkage to chromosome 11p12 in two Maltese families with a highly penetrant form of osteoporosis.
    Eur J Hum Genet, 15(7): 800-9. [Abstract] [Full-text]
11. Calcium phosphate cements to control bleeding in osteoporotic sternums.
    Ann Thorac Surg, 84(1): 259-61. [Abstract] [Full-text]
12. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Curr Med Res Opin, 23(6): 1341-9. [Abstract] [Full-text]
13. Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects.
    Hum Mutat, 28(7): 732-8. [Abstract] [Full-text]
14. A program with a dedicated coordinator improved chart documentation of osteoporosis after fragility fracture.
    Osteoporos Int, 18(8): 1127-36. [Abstract] [Full-text]
15. Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.
    Osteoporos Int, 18(8): 1047-61. [Abstract] [Full-text]
16. Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis.
    Osteoporos Int, 18(8): 1091-100. [Abstract] [Full-text]
17. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.
    Osteoporos Int, 18(8): 1033-46. [Abstract] [Full-text]
18. A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
    Osteoporos Int, 18(8): 1023-31. [Abstract] [Full-text]

© 2004-2008 Osteoporosis Research Today. All Rights Reserved.